Lasa Supergenerics Ltd

As of 19-Nov, Lasa Supergenerics Ltd is priced at 10.27, showing a slight increase but trading below all key moving averages, indicating a bearish trend. The stock has significantly underperformed over the year and five years, with a recent decline contrasting with the broader market's gains, suggesting ongoing investor caution.

Lasa Supergeneri has experienced significant fluctuations in financial performance, with net sales declining from a peak of 202.38 Cr in March 2021 to 142.45 Cr by March 2025, and operating profit turning negative in March 2023 before improving slightly to 6.27 Cr in March 2025. The company has also seen a decrease in reserves and earnings per share, with a negative profit before tax of -19.38 Cr in March 2025.

As of 11-Nov, Lasa Supergenerics Ltd's stock price is at 10.76, down 4.95%, with an overall decline of 8.03% over the last five days. The stock is underperforming significantly compared to the Sensex, which has gained 7.34% year-to-date, indicating specific challenges for the company despite favorable market conditions.

As of 30-Oct, Lasa Supergenerics Ltd is currently priced at 11.80, reflecting a 2.52% increase and a strong recent performance with a 9.46% gain over four days. Despite a significant year-to-date decline of 54.33%, the stock's recent upward trend and increased delivery volume suggest potential recovery, outperforming the Sensex in the short term.

As of 23-Oct, Lasa Supergenerics Ltd is experiencing a short-term price increase to 11.14, with a 4.5% gain today and a total return of 9.65% over the last two days, despite a year-to-date decline of 56.89%. The stock has seen increased investor participation, but long-term performance remains weak compared to the broader market.

As of 15-Oct, Lasa Supergenerics Ltd is priced at 10.31 with no change, reflecting a bearish trend as it trades below all key moving averages and has seen an 83.38% drop in delivery volume. The stock has experienced significant losses, with a year-to-date decline of 60.10%, underperforming compared to the Sensex, which has gained 5.72% year-to-date.

As of 09-Oct, Lasa Supergenerics Ltd is seeing a price increase to 11.64, up 1.13%, but has significantly underperformed over the long term with a 54.95% year-to-date decline. Despite today's uptick, the stock's short-term performance remains weak compared to the market benchmark.

As of 24-Sep, Lasa Supergenerics Ltd's stock price is at 11.80, down 3.91%, with a total decline of 13.87% over the last four days and a year-to-date return of -54.33%. The company faces operational challenges and liquidity issues, leading to significant underperformance against market benchmarks and waning investor confidence.

As of 23-Sep, Lasa Supergenerics Ltd's stock price is at 12.28, down -4.95% and has underperformed significantly with a -10.36% decline over the last three days. Weak financials, poor debt servicing ability, and a -55.94% return over the past year indicate ongoing challenges and declining investor confidence.

As of 22-Sep, Lasa Supergenerics Ltd's stock price has declined to 12.92, down 5.0%, reflecting ongoing poor financial performance and significant underperformance against market benchmarks. The company faces challenges with operating losses, weak debt servicing ability, and waning investor interest, contributing to a year-to-date drop of 50.00%.

Lasa Supergenerics Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, faced significant trading activity today, reaching its lower circuit limit. The stock has declined for four consecutive days, with a notable drop in investor participation and delivery volume, indicating ongoing market challenges.

Lasa Supergenerics Ltd is experiencing notable selling pressure, with consecutive losses leading to a significant decline in its stock price. The company has underperformed compared to the broader market, reflecting a substantial drop over the year and five years, despite some recent slight gains. Market sentiment and company-specific challenges may be influencing this trend.

As of 19-Sep, Lasa Supergenerics Ltd is priced at 13.60, down 0.73%, with significant operational challenges and a year-long decline of 49.74%. Despite a recent short-term gain of 16.44%, the company's weak fundamentals and consistent underperformance against benchmarks indicate a risky investment.